This Is Just Rewrite To Avoid Plagiarisma Medication Error I

This Is Just Rewrite To Avoid Plagiarisma Medication Error Is An Error A medication error constitutes any mistake—whether of commission or omission—that occurs at any stage from prescribing to the patient receiving the medication (Agency for Health Care Research and Quality, 2019). Research by Da Silva and Krishnamurthy (2016) indicates that preventable medication errors affect over 7 million patients annually and incur costs nearing $21 billion across different healthcare settings. Approximately 30% of hospitalized patients experience at least one discrepancy related to their medication upon discharge. These errors are underreported yet significantly impact patient safety, healthcare providers, and the economy. An illustrative case involves a 71-year-old woman who mistakenly received thiothixene (Navane), an antipsychotic medication, instead of her prescribed antihypertensive, amlodipine (Norvasc), over a span of three months. During this period, she endured physical and psychological issues including mobility challenges, tremors, mood fluctuations, and personality alterations, leading to multiple hospital visits. Despite various healthcare encounters, these symptoms were overlooked. Her medication reconciliation at admission revealed she was taking metoprolol, doxazosin, alprazolam, citalopram, and thiothixene. Further investigation into her pharmacy records confirmed she had been dispensed Navane instead of Norvasc, which she had taken as prescribed for three months. The prescription written for her medications was legible, yet the adverse effects prompted a diagnosis of drug-induced Parkinsonism related to thiothixene. Discontinuing the medication led to clinical improvement. To prevent similar medication errors, Da Silva and Krishnamurthy (2018) recommend implementing several safety measures, such as providing clear instructions with indications on every prescription, utilizing electronic health records (EHR) to review outpatient medication history, and fostering a culture open to discussing errors within the healthcare system. Strategies include the involvement of medication review teams during patient admission and discharge, collaborative rounding with pharmacists, encouraging healthcare trainees and educators to question medication indications, and sharing data on medication errors and adverse events at national and institutional levels. Mandatory training programs should be instituted for healthcare providers who do not adequately document and reconcile medications. As a nurse practitioner, vigilance during patient evaluations is crucial, especially when treatment responses are suboptimal or unusual symptoms develop. In such cases, reviewing medication lists and pill bottles should be part of the initial assessment. Implementing multiple